Manufacturer record
Cureza Healthcare Pvt. Ltd. 63/1: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Cureza Healthcare Pvt. Ltd. 63/1 (Madhya Pradesh) were declared Not of Standard Quality between November 2025 and July 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
2 records linked to Cureza Healthcare Pvt. Ltd. 63/1 in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Oral Rehydration salts IP(ORS) | CHPLO- 002Mfg 2026-02 · Exp 2028-01 | The sample does not conform to claim as per IP in respect to test for DescriptionDescription | SDTL, JharkhandState lab | Jul 2026 |
| Pantoprazole Gastro-resistant Tablets IP 40 mg | CHPLT672Mfg 2025-01 · Exp 2026-12 | The sample does not conform to IP with respect to test for "Dissolution" and "Description".Dissolution | CDL, KolkataCDSCO lab | Nov 2025 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.